Nucynta Approval History

• FDA approved: Yes (First approved November 20th, 2008)
• Brand name: Nucynta
• Generic name: tapentadol
• Company: Ortho-McNeil-Janssen Pharmaceuticals, Inc.
• Treatment for: Pain

Nucynta (tapentadol) is a centrally acting oral analgesic indicated for the relief of moderate to severe acute pain.

FDA Approval History for Nucynta

Date	Article
Aug 29, 2012	FDA Approves Nucynta ER (tapentadol) Extended-Release Oral Tablets for the Management of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Aug 26, 2011	Nucynta ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe Chronic Pain
Nov 21, 2008	FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain
Jan 24, 2008	New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets

See also...

Nucynta (tapentadol) Consumer Information

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.